Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Etf Ticker Symbol | Market | Type |
|---|---|---|---|
| Loncar China BioPharma | CHNA | NASDAQ | Exchange Traded Fund |
| Price Change | Change Percent | Etf Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 13.53 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 13.53 | 13.53 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 13.53 - 17.13 |
| Last Trade Time | Type | Quantity | Etf Price | Currency |
|---|---|---|---|---|
| - | 0 | 13.53 | USD |
Loncar China BioPharma Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.72M | - | - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
News Loncar China BioPharma
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
CHNA Historical
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 16.76 | 17.13 | 13.53 | 15.01 | 472 | -3.23 | -19.27% |
| 3 Years | 46.25 | 49.01 | 13.35 | 29.20 | 1,918 | -32.72 | -70.75% |
| 5 Years | 22.02 | 49.01 | 13.35 | 28.87 | 3,240 | -8.49 | -38.56% |
| The investment seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index (the index). Under normal circumstances, at least 80% of the funds total assets (exclusive of any collateral held from securities lending) will be invested in the component securities of the index or in depositary receipts representing such component securities. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of Chinas pharmaceutical and biotech related industries. The fund is non-diversified. |
